Merck Scores US FDA Approval For Subcutaneous Keytruda Qlex

 
• By Alaric DeArment
  
Keytruda Qlex was approved nine months after the FDA cleared Opdivo Qvantig (Shutterstock)

More from New Products

More from Scrip